Resources
-
Genetic Medicine Characterization via 2nd and 3rd Generation Sequencing Tools
Speaker Presentation: WCBP 2025
Ostrander Elizabeth, Pfizer, Inc., 2025 -
Troublesome Issues Seen in Biologics Development in Academic Spaces and Small Startup Companies
Speaker Presentation: WCBP 2025
Levi Mark, RTI International, 2025 -
Managing More With Less – the Power of Platforms
Speaker Presentation: WCBP 2025
Lequeux Isabelle, BioPhorum, 2025 -
Overcoming Low Endotoxin Recovery from Theory to Practice
Speaker Presentation: WCBP 2025
Hankins Jessica Vencill, Bristol-Myers Squibb Company, 2025 -
MRNA Technology Transfer Programme: Towards a Better Prepared Global South
Speaker Presentation: WCBP 2025
Grilo António, Medicines Patent Pool (MPP), 2025 -
Initiatives from Industry: An Update from the PSCI Horseshoe Crab Blood Working Group
Speaker Presentation: WCBP 2025
Duncanson Phil, AstraZeneca, 2025 -
Predictive Stability for Biologics Using Kinetic Modeling
Speaker Presentation: WCBP 2025
Dillon Michael, Merck & Co., Inc., 2025 -
Delivering COVID Variant Vaccines in <100 days
Speaker Presentation: WCBP 2025
Daniels Carly, Pfizer, Inc., 2025 -
Starting the Reliance Pathway for Biological Products:the ISP Chile Experience
Speaker Presentation: WCBP 2025
Crisostomo Jose, Instituto de Salud Pública de Chile, 2025 -
How Industry and Regulatory Innovation and Collaboration Can Promote the Transition From in Vivo to in Vitro Potency Testing for Human Legacy Vaccines
Speaker Presentation: WCBP 2025
Coppens Emmanuelle, Sanofi, 2025 -
Bacterial Endotoxin Testing: Progressive Science and Sustainability
Speaker Presentation: WCBP 2025
Bolden Jay, Eli Lilly and Company, 2025 -
Considerations for Developing an Autoinjector Control Strategy: A Case Study
Speaker Presentation: WCBP 2025
Benokraitis Kristin, Biogen, 2025 -
Replacement of in vivo
Immunogenicity Assay with
in vitro Antigenicity ELISA
for Pertactin Antigen in
Acellular Pertussis
Combination Vaccines
Speaker Presentation: WCBP 2025
Ljutic Belma, Sanofi, 2025 -
What Do Crabs Have to Do with Birds Have to Do with People?
Speaker Presentation: WCBP 2025
Bamford Holly, National Fish & Wildlife Foundation, 2025 -
How to Effectively Manage CMC Post-Approval Changes
Speaker Presentation: WCBP 2025
Armando John, Genentech, a Member of the Roche Group, 2025 -
Practical and Regulatory Considerations for Machine Learning Models Applied to Process Development and Control
Speaker Presentation: CMC Strategy Forum North America 2025
Stevens Ben, GlaxoSmithKline, 2025 -
Enhanced Approaches Support Robust Harmonized Vaccine Potency Specifications
Speaker Presentation: CMC Strategy Forum North America 2025
Smith Dean, Health Canada, 2025 -
Regulatory Expectations for Data Models to Support a Marketing Application
Speaker Presentation: CMC Strategy Forum North America 2025
Siggers Jayda, Health Canada, 2025 -
Enhanced Approaches to Setting Specifications – A Regulatory Perspective
Speaker Presentation: CMC Strategy Forum North America 2025
Siggers Jayda, Health Canada, 2025 -
Development of Realistic and Safe AI/ML Applications for Biotherapeutic Characterization and Process Development
Speaker Presentation: CMC Strategy Forum North America 2025
Shaver Jeremy, Pfizer, Inc., 2025